FDA approves Duchenne gene therapy with hefty $3.2m price tag
Sarepta will now need to complete a confirmatory trial to prove the therapy improves physical function and mobility.
Sarepta will now need to complete a confirmatory trial to prove the therapy improves physical function and mobility.
What's Your Reaction?
